EGFR and non-small cell lung carcinoma: Similarly, HARMONY (NCT05153408) is a phase I/II clinical trial evaluating the safety, tolerability, and anticancer activity of BLU-701 alone or in combination with osimertinib or platinum-based chemotherapy in EGFR-mutant NSCLC.